SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED

Autres langues Sun Pharma Advanced Research Company Limited

Actions

SPARC

INE232I01014

Temps Différé NSE India S.E. Autres places de cotation 11:12:08 02/05/2024			Varia. 5j.	Varia. 1 janv.
238 ^INR	+2,48 %		-20,77 %	-17,09 %

15/04	Transcript : Sun Pharma Advanced Research Company Limited - Special Call
10/04	Sun Pharma Advanced Research Company Limited annonce les résultats de l'analyse intermédiaire planifiée de l'étude PROSEEK sur le vodobatinib chez les patients atteints de la maladie de Parkinson à un stade précoce	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sun Pharma Advanced Research Company Limited Announces Results from the Planned Interim Analysis of the PROSEEK Study of Vodobatinib in Patients with Early Parkinson's Disease	10/04
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	05/02
Ocular Hypertension Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023 \| Nicox, Qlaris Bio, TheratOcular Biotek Co., Ltd., Ocular Therapeutix, Whitecap Biosciences, and others.	06/12
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	06/11
Sun Pharma Advanced Research Company Limited Announces Retirement of Chitturi Trinadha Rao as Senior Vice President, Drug Discovery	02/11
Sun Pharma Advanced Research : Update on Clinical Programs and R&D Pipeline	02/11
Sun Pharma Advanced Research : SPARC enters into an exclusive worldwide license agreement for SCD-153 with JHU and IOCB	02/11
Sun Pharma Advanced Research : SPARC Completes Enrolment in PROSEEK, A Global Phase 2 Study of Vodobatinib in Early Parkinson’s Disease	30/10/23
Sun Pharma Advanced Research Company Ltd. Completes Enrolment in Proosek, A Global Phase 2 Study of Vodobatinib in Early Parkinson's Disease	30/10/23
Sun Pharma Advanced Research : SPARC to Provide Update on Clinical Programs and R&D Pipeline	19/10/23
Sun Pharma Advanced Research Company Limited Announces Incorporation of Wholly Owned Subsidiary Company	26/09/23
Sun Pharma Advanced Research Company Limited Appoints Kajal Damania as Company Secretary	22/09/23
Sun Pharma Advanced Research Company Limited Announces the Resignation of Mr. Dinesh Lahoti as Company Secretary and Compliance Officer	11/09/23
Sun Pharma Advanced Research : AGM Speech 2022-23	07/08/23
Sun Pharma Advanced Research Company Limited Announces Resignation of Dinesh Lahoti as Company Secretary and Compliance Officer, Effective September 11, 2023	07/08/23
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	07/08/23
Sun Pharma Advanced Research : FDA issues complete response letter for PDP-716 NDA due to inspection findings at third-party API manufacturing facility	13/07/23
Sun Pharma Advanced Research Company Limited Announces That FDA Issues Complete Response Letter for Pdp-716 Nda Due to Inspection Findings At Third-Party Api Manufacturing Facility	13/07/23
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	22/05/23
Indian shares open higher as SVB acquisition hopes aid sentiment	27/03/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sun Pharma Advanced Research Company Limited

Actions

SPARC

INE232I01014

Autres langues

Filtres